Arcus Biosciences Inc (RCUS) stock is higher by 96.36% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives RCUS stock a score of 78 out of a possible 100. That rank is mainly influenced by a long-term technical score of 90. RCUS's rank also includes a short-term technical score of 73. The fundamental score for RCUS is 70. In addition to the average rating from Wall Street analysts, RCUS stock has a mean target price of $60.40. This means analysts expect the stock to rise 64.49% over the next 12 months.
Is Arcus Biosciences Inc (RCUS) Stock a Bad Value?
RCUS has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on RCUS!